Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07073443

Evaluation of the Effect of Memory-based Reminiscence Therapy

The main objective of this study is to examine the effects of memory-based recall therapy applied to elderly adults diagnosed with Stage 0, 1, and 2 dementia on their mental state, psychological flexibility, and cognitive flexibility.

The original flow plan created in the study is not found in the literature. Therefore, presenting the effects of memory-based recall on cognition in the literature may demonstrate that the contents of classical recall therapy can also be effectively restructured with cognitive effects. From this perspective, the aim is to make recommendations for "advanced psychiatric nursing practices."

Research Hypotheses:

H0: Memory-based recall therapy has no effect on mental state, psychological flexibility, and cognitive flexibility in individuals with early-stage dementia.

H1: Memory-based Recall Therapy has an effect on mental state, psychological flexibility, and cognitive flexibility in individuals with early-stage dementia.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kahramanmaraş Istiklal Universty

Kahramanmaraş, Turkey (Türkiye)

About this study

Memory therapy is very important for elderly people with declining cognitive functions, as it can stimulate various senses such as touch, taste, and smell. Materials that facilitate recall can be used in therapy. Physical objects that the elderly can look at and touch provide the patient with additional sources of information, draw their attention to the topics being discussed, and refocus them. In addition, Memory Therapy is a good method for recalling memories and movements that are not readily available or otherwise inaccessible.

The study will be conducted with elderly individuals who have applied to community health centers based in Kahramanmaraş or to the neurology and psychiatry departments of tertiary hospitals. The sample size of 573 was determined based on data obtained from outpatient clinics and community health units (diagnosis sites). At least 114 participants must be reached. Data collection will utilize the Demographic Information Form, Standardized Mini Mental Test (SMMT), Psychological Flexibility Scale, and Cognitive Flexibility Scale. The data will be collected by the researcher in two stages, pre-test and post-test, from all elderly individuals through face-to-face interviews. The elderly in the intervention group will undergo 10 sessions of Memory Therapy, twice a week for five weeks. The sessions will be planned to last an average of 45 minutes. During the 10 sessions of Memory-Based Recall Therapy applied to the intervention group, memory-enhancing phenomena will be used, and verbal reminders will be provided during repeated narratives.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Receiving outpatient treatment for dementia from the relevant departments of hospitals
  • At the time of the interviews, the doctor must have diagnosed mild dementia. (Stages 0, 1, and 2)
  • No problems with understanding or speaking Turkish
  • Being literate
  • Being in the 65 and older age group
  • No other psychiatric or neurological disorders

Exclusion criteria

  • Not having been diagnosed with dementia during the study
  • Having other chronic cognitive and psychiatric illnesses
  • Being in an advanced stage of dementia
  • Those who withdrew from the study during the interview or refused to participate in the study

Treatment and study plan

Experimental: Memory Therapy Group

Behavioral

Evaluation of the Effect of Memory-Based Recall Therapy on the Cognitive Status, Psychological Flexibility, and Cognitive Flexibility of Elderly Individuals Diagnosed with Dementia

Primary outcomes

  1. Standardized Mini Mental Test

    Time frame: 0 weeks

    The original Mini Mental Test developed by Folstein et al. (1975) and the standardized version created by Molloy and Standish (1997) are easy to administer and provide information about the degree of cognitive impairment. The lowest possible score on the scale is "0," and the highest possible score is "30." Based on the scores obtained, 0-12 points indicate "severe" cognitive impairment, 13-22 points indicate "moderate" cognitive impairment, 23-24 points indicate 'mild' cognitive impairment, and 25-30 points indicate "no cognitive impairment."

  2. Standardized Mini Mental Test

    Time frame: 5 weeks

    The original Mini Mental Test developed by Folstein et al. (1975) and the standardized version created by Molloy and Standish (1997) are easy to administer and provide information about the degree of cognitive impairment. The lowest possible score on the scale is "0," and the highest possible score is "30." Based on the scores obtained, 0-12 points indicate "severe" cognitive impairment, 13-22 points indicate "moderate" cognitive impairment, 23-24 points indicate 'mild' cognitive impairment, and 25-30 points indicate "no cognitive impairment."

  3. Psychological Flexibility Scale

    Time frame: 0 weeks

    The scale developed by Francis et al. in 2016 was translated into Turkish by Karakuş and Akbay (2020) and underwent validity and reliability testing. The scale consists of 28 items and is a 7-point Likert scale (1 = strongly disagree, 7 = strongly agree). The Cronbach's alpha value for the total scale in the Turkish validity and reliability study was 0.79, 0.84 for the values and values-based behavior subscale, 0.60 for the "being in the moment" subscale, 0.72 for the 'acceptance' subscale, 0.73 for the "contextual self" subscale, and 0.59 for the "separation" subscale.

  4. Psychological Flexibility Scale

    Time frame: 5 weeks

    The scale developed by Francis et al. in 2016 was translated into Turkish by Karakuş and Akbay (2020) and underwent validity and reliability testing. The scale consists of 28 items and is a 7-point Likert scale (1 = strongly disagree, 7 = strongly agree). The Cronbach's alpha value for the total scale in the Turkish validity and reliability study was 0.79, 0.84 for the values and values-based behavior subscale, 0.60 for the "being in the moment" subscale, 0.72 for the 'acceptance' subscale, 0.73 for the "contextual self" subscale, and 0.59 for the "separation" subscale.

  5. Cognitive Flexibility Inventory

    Time frame: 0 weeks

    Cognitive Flexibility Inventory (CFI) The Cognitive Flexibility Inventory (CFI) is a short self-report scale developed to measure cognitive flexibility, which is necessary for individuals to adapt to changing environmental stimuli and replace maladaptive thoughts with more balanced and adaptive ones. The scale yields three distinct types of scores: a total cognitive flexibility score, an "alternatives" subscale score, and a "control" subscale score. Higher scores indicate greater cognitive flexibility. The Cronbach's alpha coefficient for the entire scale was found to be .90.

  6. Cognitive Flexibility Inventory

    Time frame: 5 weeks

    Cognitive Flexibility Inventory (CFI) The Cognitive Flexibility Inventory (CFI) is a short self-report scale developed to measure cognitive flexibility, which is necessary for individuals to adapt to changing environmental stimuli and replace maladaptive thoughts with more balanced and adaptive ones. The scale yields three distinct types of scores: a total cognitive flexibility score, an "alternatives" subscale score, and a "control" subscale score. Higher scores indicate greater cognitive flexibility. The Cronbach's alpha coefficient for the entire scale was found to be .90.

Sponsors and collaborators

Lead sponsor

Kahramanmaraş İstiklal University

Other

Registry information

Official study title

Evaluation of the Effect of Memory-based Reminiscence Therapy on Cognitive Status, Psychological Flexibility and Cognitive Flexibility in Older People With Dementia

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jul 18, 2025
Registry last updated
Jul 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.